|
28.07.25 - 11:12
|
XFRA: SPAFR - HANDELSUNTERBRECHUNG IN DIVERSEN AUSLANDSAKTIEN - TEIL 5 (XETRA)
|
|
CA37640A4028
CA67010X1042
AU0000373722
CA29385B1094
CA83569N2077
DK0060816148
GB00BS3D4G58
JE00BRJ8YF63
SE0005731833
SE0012481570
AU000000APA1
AU0000033946
CA00654D2095
CA4315022026
CA45083C1086
GB00BDFGGK53
GB00BMTV7393
GG00BGDYDZ69
SE0016101844
SE0017885379
AU000000SPL0
AU000000WLD8
CA0813791096
CA3804732079
CA60306F1018
AU000000MFG4
AU0000296022
CA53044R8839
CA56658A4019
SE0020388932
AU000000OLI4
CA03820A1093
CA15234A4000
CA30222R1091
CA0037351073
CA15850F1053
CA31773B5018
CA41138T1057
CA72703G2027
CA98402E2069
CNE1000003R8
JP3889200006
AU000000SSM2
SE0015658570
CA30336V1031
CA3060442074
CA3194101067
CA8552811017
IT0001469995
SE0003491562
CA45250A4063
CA7759041055
SE0000396061
AU000000ACR3
CA53680T1021
CA68237A1093
CA69867J1057
FI4000233317
SE0009921588
CA09076M1014
CA38217M1005
FR0012596468
GB00BD5JRP64
AU000000EPM8
AU0000317976
CA05455X2059
NO0010081235
SE0011311554
SE0022240115
SE0023439500
AU0000372054
CA00289A1093
CA01559R4008...
|
|
16.07.25 - 00:21
|
BIOVAXYS ANNOUNCES EXTENSION OF OFFERING CLOSING DATE (PR Newswire)
|
|
// NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES // VANCOUVER, BC, July 15, 2025 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) ("BioVaxys" or the "Company") announces an extension of its previously announced brokered......
|
|
|
20.06.25 - 08:24
|
BIOVAXYS ANNOUNCES AMENDED LIFE OFFERING (PR Newswire)
|
|
// NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES // VANCOUVER, BC, June 20, 2025 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) ("BioVaxys" or the "Company") announces that it has amended the terms of its brokered......
|
|
04.06.25 - 00:57
|
BioVaxys Issues Corporate Update (PR Newswire)
|
|
VANCOUVER, BC, June 3, 2025 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) ("BioVaxys" or the "Company") is pleased to provide a summary of current operating initiatives including the integration and disposition of assets acquired in February 2024 from the former IMV,......
|
|
|
|
|
|
|
|
|
|
|
|
02.04.25 - 00:39
|
BioVaxys Technology Corp. Announces Debt Settlement Agreement (PR Newswire)
|
|
// NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES // VANCOUVER, BC, April 1, 2025 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) ("BioVaxys" or the "Company") announces that it has entered into a debt settlement......
|
|
18.03.25 - 04:09
|
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update (PR Newswire)
|
|
VANCOUVER, BC, March 17, 2025 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") is providing this bi-weekly update on the status of the management cease trade order granted on March 3, 2025 (the "MCTO"), by its principal regulator,......
|
|
04.03.25 - 00:24
|
BioVaxys Technology Corp. Granted Management Cease Trade Order (PR Newswire)
|
|
VANCOUVER, BC, March 3, 2025 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") announces that, further to its news release dated February 13, 2025, its principal regulator, the British Columbia Securities Commission (the "BCSC"), has......
|
|
24.01.25 - 02:03
|
BIOVAXYS ANNOUNCES EXTENSION OF PRIVATE PLACEMENT CLOSING DATE (PR Newswire)
|
|
// NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES // VANCOUVER, BC, Jan. 23, 2025 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) ("BioVaxys" or the "Company") is pleased to announce, further to its news release of......
|
|
|